Document Detail


A double blind, randomized, controlled clinical trial to assess the efficacy of a new coal tar preparation (Exorex) in the treatment of chronic, plaque type psoriasis.
MedLine Citation:
PMID:  11167965     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Exorex is a new topical formulation for the treatment of psoriasis; it contains 1% coal tar and a synthetic analogue resembling components identified in banana skin (a complex of esterified essential fatty acids). To determine whether the esterified essential fatty acid complex confers any therapeutic advantage over coal tar alone, patients with chronic plaque psoriasis (n = 20) were entered into a double-blind, randomized, right/left comparison of Exorex, and Exorex without the essential fatty acid component (known hereafter as coal tar control) for 8 weeks. Target plaques were scored (0-4) for erythema, desquamation and infiltration at day 0 and at 2 week intervals throughout the study. No significant differences were detected between Exorex and coal tar control with respect to changes in the summed scores at baseline and following 8 weeks of treatment (mean difference in summed score changes from baseline between Exorex and coal tar control 0.2, 95% confidence interval - 0.44 to 0.84; P = 0.52) or in the area under the response-time curve (P = 0.16). Mean percentage improvement in summed scores of target plaques were 53.9% (SE = 4%) and 56.1% (SE = 4.9%) for Exorex and coal tar control, respectively. Results suggest that the complex of esterified essential fatty acids is not exerting any clinically important therapeutic effect in the treatment of chronic plaque psoriasis.
Authors:
C H Smith; K Jackson; S Chinn; K Angus; J N Barker
Related Documents :
8837875 - Amino acid composition and chemical evaluation of protein quality of cereals as affecte...
11884015 - Specific changes in n -6 fatty acid metabolism in patients with chronic intestinal fail...
5324585 - Autoradiographic studies of bacterial chromosome replication in amino-acid deficient es...
7395785 - Amino acids and ketoacids--advantages and pitfalls.
134865 - Site of hydrolysis of collagen by hot trichloroacetic acid.
15854625 - Atr-ftir spectroscopy: a chemometric approach for studying the lipid organisation of th...
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Clinical and experimental dermatology     Volume:  25     ISSN:  0307-6938     ISO Abbreviation:  Clin. Exp. Dermatol.     Publication Date:  2000 Nov 
Date Detail:
Created Date:  2001-02-22     Completed Date:  2001-04-05     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  7606847     Medline TA:  Clin Exp Dermatol     Country:  England    
Other Details:
Languages:  eng     Pagination:  580-3     Citation Subset:  IM    
Affiliation:
Skin Therapy Research Unit, St John's Institute of Dermatology, St Thomas' Hospital, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Administration, Topical
Adult
Coal Tar / administration & dosage*,  adverse effects
Double-Blind Method
Drug Combinations
Fatty Acids, Essential / administration & dosage*,  adverse effects
Female
Humans
Male
Middle Aged
Psoriasis / drug therapy*
Treatment Outcome
Chemical
Reg. No./Substance:
0/Drug Combinations; 0/Fatty Acids, Essential; 8007-45-2/Coal Tar
Comments/Corrections
Comment In:
Clin Exp Dermatol. 2001 Jul;26(5):459-60   [PMID:  11488843 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Intracellular glutathione regulates tumour necrosis factor-alpha-induced p38 MAP kinase activation a...
Next Document:  Topical sucralfate in the management of peristomal skin disease: an open study.